retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...

Prescription medication injuries are a major concern that call for quick attention and response. The first things you should ...

Paul Howe, chief commercial officer at Protega Pharma, discusses how regulatory agencies are updating their policies based on the presence of abuse-deterrent medications. Pharmaceutical Executive: How ...

The genetic polymorphisms that may affect individual responses to cardiovascular agents are reviewed, and the application of pharmacogenetics to cardiovascular disease management is discussed.

A new tool from the state of Ohio aims to help officials proactively address heightened drug overdose risk in local ...

The program is being launched with the help of money awarded to Kentucky in settlements with pharmacies that helped fuel the ...

Six grade 5 (fatal) AEs were attributed to a study drug. Among patients treated with the phase II dose combination, objective responses occurred in 35 of 44 (80%). Median time to response was 1.4 ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...